PANACEA LIFE SCIENCES HOLDINGS, INC. (PLSH)

OTC Pharmaceutical Pharmaceutical Chemicals SIC: 2833
A+
Pipeline Grade

Financial Position (from SEC Filings)

$0.1M
Cash & Equivalents
$0.4M
Quarterly Burn Rate
1 mo
Est. Cash Runway
$2M
Market Cap

Estimated from most recent SEC quarterly filing. View SEC filings

Drug Pipeline (3 Assets)

DrugPhaseIndications
RIZATRIPTAN BENZOATE
RIZATRIPTAN BENZOATE 		APPROVED —
PRASUGREL HYDROCHLORIDE
PRASUGREL 		APPROVED —
TACROLIMUS
TACROLIMUS 		APPROVED —

Upcoming Catalysts

No upcoming catalysts detected for this company.

More Analysis

AI Stock Score

SEC EDGAR fundamental analysis with Claude AI & ChatGPT ratings for PLSH.

SEC EDGAR Filings

All SEC filings for PANACEA LIFE SCIENCES HOLDINGS, INC. on EDGAR.

Full Calendar

View all upcoming FDA catalysts across all biotech companies.